China’s Rapid Rise in Biotech Innovation Challenges U.S. Dominance
China’s burgeoning biotechnology sector took center stage at this year’s American Society of Clinical Oncology (ASCO) annual meeting in Chicago, signaling a historic shift in the global landscape of drug development. As researchers and industry executives gathered this week, they highlighted a surge in high-quality clinical trial data originating from Chinese firms, fueling growing anxiety…
